Markets
High Jump Clearing Level
(C. Morgan Engel/Getty Images)

Palantir has cleared a key technical level

But recent momentum of the retail favorite gave way to seesaw trading on Tuesday.

Matt Phillips

Palantir rebounded above its 50-day moving average and stayed there for the last three days, the first time the retail fave held that level in almost a month.

But whether the shares stay above that technical level, closely watched as an early building block of durable price momentum, remains an open question amid seesaw trading on Tuesday.

Palantir attracted a devoted following last year, when its 340% gain made it the best performer in the S&P 500 for the year, especially after it became a top “Trump trade” in the aftermath of the 2024 presidential election.

The momentum continued into 2025, when Palantir was up as much as 65% for the year at its February 18 peak, thanks to both rampant trader enthusiasm and impressive Q4 earnings results. But it was also among the worst-hit stocks in the S&P during the recent market slump, falling almost 30%.

Despite its fast-growing business — it posted roughly 30% growth in revenues — Palantir remains extraordinarily vulnerable to changes in market sentiment.

That’s because it’s arguably the single most expensive stock in the S&P 500 index, with a price-to-earnings ratio of about 170x estimated earnings over the next 12 months. Even at the peak of excitement around Nvidia back in 2023, it was only trading at about 60x earnings.

That means the level of speculative excitement among the buying public is a more important determinant of the share price than how the underlying business is doing, at least over the short term.

So the shares could continue to be highly volatile, but volatility has its benefits. Even after the rollercoaster ride of the first three months of 2025, Palantir is the fourth-best performer in the S&P 500, with a year-to-date gain of more than 25%.

More Markets

See all Markets
markets

Spectrum owner Charter Communications is on pace for its worst day ever as broadband numbers and Q1 results disappoint

Cable and broadband company Charter Communications is on pace for its worst-ever trading day on Friday, as investors dump the stock following its Q1 results and forward guidance.

Charter, which owns Spectrum, reported adjusted earnings of $9.17 per share, below Wall Street estimates of $9.96 per share from analysts polled by FactSet. On the company’s earnings call, CFO Jessica Fischer appeared to lower its guidance for full-year revenue per user.

“It’ll be close either way in terms of whether we end up with net growth,” Fischer said.

The company lost 120,000 internet subscribers in the quarter, deeper than the expected 94,800 and double its loss from the same period last year. That news comes one day after Comcast’s earnings provided a bit of optimism for broadband as a category: the company reported Q1 losses of 65,000, significantly improving from 183,000 losses in the same quarter last year. Comcast is down more than 10%, on pace for its worst day since January 2025.

markets

Nvidia poised to snap longest run without a record close since the AI boom began

The stock price of the company responsible for the brains of the AI boom is finally showing some brawn again.

Nvidia, the world’s most valuable company, is poised to close at a record high for the first time since October 29, 2025, on Friday (if it ends above $207.04).

The AI chip trade is on fire, with the Philadelphia Semiconductor Index slated to deliver its 18th consecutive gain as Intel’s robust results and outlook juice the entire ecosystem. Hyperscalers report earnings next week, and their capex guidance can be thought of as the earnings guidance for Nvidia and other AI suppliers for the quarters to come.

This would end Nvidia’s longest stretch without a record close since the unofficial start of the AI boom (when the chip designer delivered blowout quarterly results in May 2023).

(Sorry if I jinx this!)

markets

Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week

Eli Lilly fell on Friday after prescription data for its new weight-loss pill, Foundayo, showed that it’s having a significantly slower rollout than its top competitor.

The pill was prescribed about 3,700 times in its second week, according to IQVIA data cited by Deutsche Bank analysts, compared to the roughly 8,000 they were expecting. Novo Nordisk’s Wegovy pill, which came out in January, hit over 18,000 prescriptions in its second week.

The FDA approved Foundayo on April 1 and shipments began on April 9. Deutsche analysts noted that Lilly’s GLP-1 injections, which currently outsell Novo’s, also had a slower start.

Lilly fell more than 4% after the numbers were released. Novo Nordisk rose more than 5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.